| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/07/2007 | EP1749527A1 Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| 02/07/2007 | EP1749526A1 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 02/07/2007 | EP1749523A1 GSK-3 inhibitors |
| 02/07/2007 | EP1749520A1 Water-dispersible encapsulated sterols |
| 02/07/2007 | EP1749002A1 Pyrrole or imidazole amides for treating obesity |
| 02/07/2007 | EP1748776A1 Compositions for affecting weight loss |
| 02/07/2007 | EP1748774A1 Compositions comprising flavonoids and tocotrienols and methods thereof |
| 02/07/2007 | EP1748773A1 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 02/07/2007 | EP1748768A1 Novel compositions comprising higher primary alcohols and nicotinic acid and process of preparation thereof |
| 02/07/2007 | EP1748761A2 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
| 02/07/2007 | EP1626716B1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/07/2007 | EP1506211B1 C-aryl glucoside sglt2 inhibitors and method |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | CN1910201A Glucagon-like peptide-1 analogs with long duration of action |
| 02/07/2007 | CN1910182A Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| 02/07/2007 | CN1910181A Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| 02/07/2007 | CN1910168A Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors |
| 02/07/2007 | CN1910163A Antidiabetic oxazolidinediones and thiazolidinediones |
| 02/07/2007 | CN1910150A Piperidine derivatives as GCS inhibitors |
| 02/07/2007 | CN1909903A Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
| 02/07/2007 | CN1909902A Triazole, oxadiazole and thiadiazole derivatives as PPAR modulators for the treatment of diabetes |
| 02/07/2007 | CN1908156A Monascus novel strain and traditional Chinese medicine monascus prepared by fermenting the same |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1907978A Vibralactone, preparation method and medicinal application thereof |
| 02/07/2007 | CN1907959A New crystalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 02/07/2007 | CN1907958A New crystalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 02/07/2007 | CN1907957A Crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 02/07/2007 | CN1907949A Calcium receptor-active compounds |
| 02/07/2007 | CN1907495A Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion |
| 02/07/2007 | CN1907490A Application of NYGGF4 gene sequence for preparing medicine affecting lipocyte proliferation |
| 02/07/2007 | CN1907435A Production technique for Guli powder |
| 02/07/2007 | CN1907394A Medicine for treating diabetes foot |
| 02/07/2007 | CN1907390A Oral liquid for treating diabetes dry-thirsty and its preparing process and application |
| 02/07/2007 | CN1907386A Chinese traditional medicinal composition for treating hyperlipemia, hypertension, and coronary disease |
| 02/07/2007 | CN1907357A Compound recipe pollen extract oral liquid for regulating blood pressure and blood fat, and process for preparing same |
| 02/07/2007 | CN1907326A Drug for treating neurous system diseases, cardiovascular and cerebrovascular diseases, and neuropathic pain |
| 02/07/2007 | CN1907299A Oral liquor containing biological protein and its preparing method |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298703C Cyanopyrolidine derivatives |
| 02/07/2007 | CN1298688C Technique for extracting and preparing policosanol and application |
| 02/07/2007 | CN1298367C Blood sugar reducing health article |
| 02/07/2007 | CN1298363C Health product for assisting blood sugar-decreasing function and its preparation method |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173061 For diagnosis or in vivo imaging of Amyloid-associated diseases such as diabetes; radiolabelled |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173043 Heteroaromate OSC inhibitors |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172778 isomers of reduced folate selected from (6S)-tetrahydrofolic acid, 5-methyl-(6S)-tetrahydrofolic acid, 5-formyl-(6S)-tetrahydrofolic acid, 10-formyl-(6R)-tetrahydrofolic acid, 5,10-methylene-(6R)-tetrahydrofolic acid, 5,10-methenyl-(6R)-tetrahydrofolic acid; vitamin B6; birth defect prevention |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/05/2007 | CA2518579A1 Method for appetite suppression |
| 02/01/2007 | WO2007013929A1 Aniline sulfonamide derivatives and their uses |
| 02/01/2007 | WO2007013824A1 Biologically active extracts from stephania brachyandra |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2007013689A1 Cyclopropanecarboxylic acid compound |
| 02/01/2007 | WO2007013522A1 Simon potato extract, glycosphingolipid derived from simon potato, and process for production of the extract or glycosphingolipid |
| 02/01/2007 | WO2007013501A1 Growth promoting agent and life prolonging agent |
| 02/01/2007 | WO2007013494A1 Drug containing phosphate ion as blood glucose level-controlling agent |
| 02/01/2007 | WO2007013438A1 Anti-obesity agent and anti-obesity food |
| 02/01/2007 | WO2007013062A1 Composition and method for weight maintenance |
| 02/01/2007 | WO2007012670A2 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists |
| 02/01/2007 | WO2007012661A1 Hydantoin derived compounds and use thereof as mchr-1 antagonists |
| 02/01/2007 | WO2006002802A8 Phenyl derivatives comprising an acetylene group |
| 02/01/2007 | WO2003058203A3 Extended glucagon-like peptide-1 analogs |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027198 Crystal of heterocyclic compound |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027196 Activator of peroxisome proliferator-activated receptor delta |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027151 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes |
| 02/01/2007 | US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/01/2007 | US20070026091 Preparation and Administration of Jojoba Product for Reducing Weight, Fat and Blood Lipid Levels and for the Prevention and Treatment of Cancer |
| 02/01/2007 | US20070026088 a powder extracted from hardened antlers which contains 0.5 ng of insulin and insulin-like growth factor-I in the quantity of 18 ng per 1 g using ion exchange chromatography; hypoglycemic agent |
| 02/01/2007 | US20070026050 Mortierella schmuckeri microorganisms are cultured in fermentation medium; a polyunsaturated fatty acid for use in e.g. infant formulas |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |